dehydroepiandrosterone sulfate has been researched along with Paranoia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johansson, AG; Landén, M; Nikamo, P; Schalling, M | 1 |
Costa, MM; De Souza, E; Kramer, JH; Newhouse, P; Peskind, E; Raskind, M; Reus, VI; Roberts, E; Sack, D; Sadowsky, C; Walton, P; Wolkowitz, OM; Yaffe, K | 1 |
1 trial(s) available for dehydroepiandrosterone sulfate and Paranoia
Article | Year |
---|---|
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Akathisia, Drug-Induced; Alzheimer Disease; Cognition; Confusion; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Neuroprotective Agents; Nootropic Agents; Paranoid Disorders; Patient Dropouts; Pilot Projects; Reproducibility of Results; Severity of Illness Index; Treatment Outcome | 2003 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Paranoia
Article | Year |
---|---|
Polymorphisms in AKR1C4 and HSD3B2 and differences in serum DHEAS and progesterone are associated with paranoid ideation during mania or hypomania in bipolar disorder.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Bipolar Disorder; Dehydroepiandrosterone Sulfate; Female; Genetic Predisposition to Disease; Haplotypes; Humans; Hydrocortisone; Male; Membrane Proteins; Oxidoreductases; Paranoid Disorders; Polymorphism, Single Nucleotide; Progesterone; Progesterone Reductase; Sex Characteristics | 2012 |